|
1.
|
|
14 p, 2.9 MB |
Exploring the link between MORF4L1 and risk of breast cancer
/
Martrat, Griselda (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Maxwell, Christopher A. (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Tominaga, Emiko (The University of Texas Health Science Center at San Antonio) ;
Porta de la Riva, Montserrat (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Bonifaci, Núria (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Gomez-Baldo, Laia (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Lazaro, Conxi (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Blanco Guillermo, Ignacio (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Brunet, Joan (Hospital Joan Trueta (Girona, Catalunya)) ;
Aguilar, Helena (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Fernandez-Rodriguez, Juana (Hospital Joan Trueta (Girona, Catalunya)) ;
Seal, Sheila (Institute of Cancer Research (Sutton, Regne Unit)) ;
Renwick, Anthony (Institute of Cancer Research (Sutton, Regne Unit)) ;
Rahman, Nazneen (Institute of Cancer Research (Sutton, Regne Unit)) ;
Kühl, Julia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Neveling, Kornelia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Schindler, Detlev (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ;
Ramírez de Haro, Ma. José (María José) (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Castellà, María (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Hernández Viedma, Gonzalo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Easton, Douglas F. (University of Cambridge. Department of Public Health and Primary Care) ;
Peock, Susan (University of Cambridge. Department of Public Health and Primary Care) ;
Cook, Margaret (University of Cambridge. Department of Public Health and Primary Care) ;
Oliver, Clare T. (University of Cambridge. Department of Public Health and Primary Care) ;
Frost, Debra (University of Cambridge. Department of Public Health and Primary Care) ;
Platte, Radka (University of Cambridge. Department of Oncology,) ;
Evans, D. Gareth (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ;
Lalloo, Fiona (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ;
Eeles, Rosalind (The Institute of Cancer Research (Sutton, Regne Unit)) ;
Izatt, Louise (Guy's and St Thomas NHS Foundation Trust (Londres, Regne Unit)) ;
Chu, Carol (Yorkshire Regional Genetics Service (Leeds, Regne Unit)) ;
Davids, Rosemarie (Ferguson-Smith Centre for Clinical Genetics (Glasgow, Regne Unit)) ;
Ong, Kai-Ren (Birmingham Women's Hospital Healthcare NHS Trust (Birmingham, Regne Unit)) ;
Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ;
Douglas, Fiona (Newcastle Upon Tyne Hospitals NHS Trust (Newcastle, Regne Unit)) ;
Hodgson, Shirley (University of London. St George's Hospital. Clinical Genetics Department) ;
Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ;
Morrison, Patrick J. (Northern Ireland Regional Genetics Centre (Belfast, Regne Unit)) ;
Porteous, Mary (South East of Scotland Regional Genetics Service (Edimburg, Regne Unit)) ;
Peterlongo, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ;
Manoukian, Siranoush (Fondazione IRCCS INT (Milà, Itàlia)) ;
Peissel, Bernard (Fondazione IRCCS INT (Milà, Itàlia)) ;
Zaffaroni, Daniela (Fondazione IRCCS INT (Milà, Itàlia)) ;
Roversi, Gaia (Fondazione IRCCS INT (Milà, Itàlia)) ;
Barile, Monica (Istituto Europeo di Oncologia (Milà, Itàlia)) ;
Viel, Alessandra (Centro di Riferimento Oncologico (Aviano, Itàlia)) ;
Pasini, Barbara (University of Turin. Department of Genetics, Biology and Biochemistry (Torí, Itàlia)) ;
Ottini, Laura (Sapienza University of Rome. Department of Molecular Medicine) ;
Putignano, Anna Laura (University of Florence. Department of Clinical Physiopathology (Florència, Itàlia)) ;
Savarese, Antonella (Regina Elena Cancer Institute (Roma, Itàlia)) ;
Bernard, Loris (IEO. Department of Experimental Oncology (Milà, Itàlia)) ;
Radice, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ;
Healey, Sue (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Spurdle, Amanda (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Chen, Xiaoqing (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Beesley, Jonathan (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ;
Rookus, Matti A. (The Netherlands Cancer Institute. Department of Epidemiology (Amsterdam, Països Baixos)) ;
Verhoef, Senno (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ;
Tilanus-Linthorst, Madeleine A. (Erasmus MC-Daniel den Hoed Cancer Center (Rotterdam, Països Baixos)) ;
Vreeswijk, Maaike P. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ;
Asperen, Christi J. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ;
Bodmer, Danielle (Radboud University Nijmegen Medical Center. Department of Human Genetics (Nijmegen, Països Baixos)) ;
Ausems, Margreet G. E. M. (University Medical Center Utrecht. Department of Medical Genetics (Utrecht, Països Baixos)) ;
van Os, Theo A. (Academic Medical Center, Department of Clinical Genetics (Amsterdam, Països Baixos)) ;
Blok, Marinus J. (University Hospital Maastricht. Department of Clinical Genetics (Maastricht, Països Baixos)) ;
Meijers-Heijboer, Hanne E. J. (VU Medical Center. Department of Clinical Genetics (Amsterdam, Països Baixos)) ;
Hogervorst, Frans B. L. (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ;
Goldgar, David E. (University of Utah School of Medicine. Department of Dermatology (Salt Lake City, Estats Units d'Amèrica)) ;
Buys, Saundra (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ;
John, Esther M. (Cancer Prevention Institute of California (Fremont, Estats Units d'Amèrica)) ;
Miron, Alexander (Dana-Farber Cancer Institute. Department of Cancer Biology (Boston, Estats Units d'Amèrica)) ;
Southey, Melissa (The University of Melbourne. Melbourne School of Population Health (Austràlia)) ;
Daly, Mary B. (Fox Chase Cancer Center. Division of Population Science (Philadelphia, Estats Units d'Amèrica)) ;
Harbst, Katja (Lund University. Department of Oncology (Lund, Suècia)) ;
Borg, Åke (Lund University. Department of Oncology (Lund, Suècia)) ;
Rantala, Johanna (Karolinska University Hospital. Department of Clinical Genetics (Estocolm, Suècia)) ;
Barbany-Bustinza, Gisela (Karolinska University Hospital. Department of Clinical Genetics (Estocolm, Suècia)) ;
Ehrencrona, Hans (Uppsala University. Departament of Genetics and Pathology (Uppsala, Suècia)) ;
Stenmark-Askmalm, Marie (Hälsouniversitetet Universitetssjukhuset. Department of Oncology (Linköping, Suècia)) ;
Kaufman, Bella (Chaim Sheba Medical Center. The Institute of Oncology (Ramat Gan, Israel)) ;
Laitman, Yael (Chaim Sheba Medical Center. The Susanne Levy Gertner Oncogenetics Unit (Ramat Gan, Israel)) ;
Milgrom, Roni (Chaim Sheba Medical Center. The Susanne Levy Gertner Oncogenetics Unit (Ramat Gan, Israel)) ;
Friedman, Eitan (Chaim Sheba Medical Center. The Susanne Levy Gertner Oncogenetics Unit (Ramat Gan, Israel)) ;
Domchek, Susan M. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Nathanson, Katherine L. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Rebbeck, Timothy R. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ;
Johannsson, Oskar Thor (20A Landspitali-LSH v/Hringbraut. Department of Oncology (Reykjavik, Islàndia)) ;
Couch, Fergus J. (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ;
Wang, Xianshu (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ;
Fredericksen, Zachary (Mayo Clinic. Department of Health Sciences Research (Rochester, Estats Units d'Amèrica)) ;
Cuadras, Daniel (Institut d'Investigació Biomèdica de Bellvitge. Statistical Assessment Service (L'Hospitalet del Llobregat, Catalunya)) ;
Moreno, Víctor (South East of Scotland Regional Genetics Service, Western General Hospital (Edimburg, Regne Unit)) ;
Pientka, Friederike K. (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ;
Depping, Reinhard (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ;
Caldés, Trinidad (Hospital Clínico San Carlos. Medical Oncology Branch (Madrid, Espanya)) ;
Osorio, Ana (Spanish National Cancer Research Centre. Human Cancer Genetics Programme (Madrid, Espanya)) ;
Benítez, Javier (Spanish National Cancer Research Centre. Human Cancer Genetics Programme (Madrid, Espanya)) ;
Bueren, Juan (Centro de Investigaciones Energéticas, Medioambientales, y Tecnológicas (Madrid, Espanya)) ;
Heikkinen, Tuomas (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ;
Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Tominaga, Kaoru (The University of Texas Health Science Center at San Antonio) ;
Cerón, Julián (Institut d'Investigació Biomèdica de Bellvitge (L'Hospitalet del Llobregat, Catalunya)) ;
Antoniou, Antonis C. (University of Cambridge. Department of Public Health and Primary Care) ;
Fert Ferrer, Sandra (Hôtel Dieu Centre Hospitalier (Chambéry, França)) ;
Collonge-Rame, Marie-Agnès (Centre Hospitalier Universitaire de Besançon (Besançon, França)) ;
Mortemousque, Isabelle (Centre Hospitalier Universitaire Bretonneau (Tours, França)) ;
McGuffog, Lesley (University of Cambridge. Department of Public Health and Primary Care) ;
Chenevix-Trench, Georgia (Queensland Institute of Medical Research (Brisbane, Austràlia)) ;
Pereira-Smith, Olivia M. (The University of Texas Health Science Center at San Antonio) ;
Nevanlinna, Heli (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ;
Hamann, Ute (Deutsches Krebsforschungszentrum (Heidelberg, Alemanya)) ;
Torres, Diana (Pontificia Universidad Javeriana. Instituto de Genética Humana (Bogota, Colòmbia)) ;
Caligo, Maria Adelaide (University Hospital of Pisa. Section of Genetic Oncology (Pisa, Itàlia)) ;
Godwin, Andrew K. (University of Kansas Medical Center. Department of Pathology and Laboratory MedicineCenter (Kansas, Estats Units d'Amèrica)) ;
Imyanitov, Evgeny N. (N.N. Petrov Institute of Oncology. Laboratory of Molecular Oncology (Sant Petersburg, Rússia)) ;
Janavicius, Ramunas (Vilnius University Hospital Santariskiu Clinics. Hematology, Oncology and Transfusion Medicine Center (Vilnius, Lituània)) ;
Sinilnikova, Olga M. (Centre Hospitalier Universitaire de Lyon. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents (Lyon, França)) ;
Stoppa-Lyonnet, Dominique (Institut Curie. Service de Génétique Oncologique (Paris, França)) ;
Mazoyer, Sylvie (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ;
Verny-Pierre, Carole (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ;
Castera, Laurent (Institut Curie. Service de Génétique Oncologique (Paris, França)) ;
de Pauw, Antoine (Institut Curie. Service de Génétique Oncologique (Paris, França)) ;
Bignon, Yves-Jean (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ;
Uhrhammer, Nancy (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ;
Peyrat, Jean-Philippe (Centre Oscar Lambret. Laboratoire d'Oncologie Moléculaire Humaine (Lille, França)) ;
Vennin, Philippe (Centre Oscar Lambret. Consultation d'Oncogénétique (Lille, França)) ;
The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) ;
The Netherlands Cancer Institute.
Hereditary Breast and Ovarian Cancer Group (HEBON) ;
University of Utah School of Medicine.
Breast Cancer Family Registry (Salt Lake City, Estats Units d'Amèrica) ;
Lund University.
Swedish Breast Cancer Study (Lund, Suècia) ;
Fédération Nationale des Centres de Lutte Contre le Cancer.
Groupe Génétique et Cancer (Lyon, França)
Introduction: Proteins encoded by Fanconi anemia (FA) and/or breast cancer (BrCa) susceptibility genes cooperate in a common DNA damage repair signaling pathway. To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens. [...]
2011 -  10.1186/bcr2862
Breast cancer research, Vol. 13, Núm. R40 (4 2011) -14
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
